Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 
EDITORIAL COMMENTARY
Year : 2017  |  Volume : 38  |  Issue : 1  |  Page : 2-3

Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology?


Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Sameer Rastogi
Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-5851.203492

Rights and Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed266    
    Printed7    
    Emailed0    
    PDF Downloaded20    
    Comments [Add]    

Recommend this journal